Dashboard
Manage Tickers

MCKMCKESSON CORP

NYSE mckesson.com


$ 530.29 $ -0.83 (-0.16 %)    

Thursday, 02-May-2024 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 4.68 (0.94 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 530.27
$ 528.25
$ 0.00 x 0
$ 0.00 x 0
$ 524.91 - $ 533.47
$ 350.91 - $ 544.81
620,116
na
70.68B
$ 0.68
$ 23.58
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-07-2024 12-31-2023 10-Q
2 11-01-2023 09-30-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-K
5 02-02-2023 12-31-2022 10-Q
6 11-02-2022 09-30-2022 10-Q
7 08-03-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-K
9 02-02-2022 12-31-2021 10-Q
10 11-01-2021 09-30-2021 10-Q
11 08-04-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-K
13 02-02-2021 12-31-2020 10-Q
14 11-03-2020 09-30-2020 10-Q
15 08-03-2020 06-30-2020 10-Q
16 05-22-2020 03-31-2020 10-K
17 02-04-2020 12-31-2019 10-Q
18 10-30-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-K
21 01-31-2019 12-31-2018 10-Q
22 10-25-2018 09-30-2018 10-Q
23 07-26-2018 06-30-2018 10-Q
24 05-24-2018 03-31-2018 10-K
25 02-01-2018 12-31-2017 10-Q
26 10-27-2017 09-30-2017 10-Q
27 07-27-2017 06-30-2017 10-Q
28 05-22-2017 03-31-2017 10-K
29 01-26-2017 12-31-2016 10-Q
30 10-27-2016 09-30-2016 10-Q
31 07-27-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-K
33 01-27-2016 12-31-2015 10-Q
34 10-29-2015 09-30-2015 10-Q
35 07-29-2015 06-30-2015 10-Q
36 05-12-2015 03-31-2015 10-K
37 02-05-2015 12-31-2014 10-Q
38 10-28-2014 09-30-2014 10-Q
39 07-31-2014 06-30-2014 10-Q
40 05-14-2014 03-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

how-is-the-market-feeling-about-mckesson
How Is The Market Feeling About McKesson?
05/02/2024 20:15:25

citigroup-maintains-buy-on-mckesson-raises-price-target-to-620
Citigroup Maintains Buy on McKesson, Raise...
04/30/2024 14:29:16

Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $575 to $620.

mckinsey-faces-criminal-probe-by-doj-for-opioid-consulting-report
McKinsey Faces Criminal Probe By DOJ For O...
04/25/2024 05:05:54

The U.S. Department of Justice is conducting a criminal investigation into the consulting firm McKinsey & Company for its r...

Core News & Articles
Evercore Says McKesson Wins OptumRX Contra...
04/22/2024 13:18:55

- Bloomberg

jim-cramer-is-willing-to-let-this-pharma-stock-catch-fire-advises-not-to-sell-mckesson
Jim Cramer Is 'Willing To Let This Pharma ...
04/19/2024 12:46:13

The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest.

morgan-stanley-maintains-overweight-on-mckesson-raises-price-target-to-548
Morgan Stanley Maintains Overweight on McK...
04/15/2024 16:40:06

Morgan Stanley analyst Erin Wright maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $522 to ...

if-you-invested-100-in-this-stock-5-years-ago-you-would-have-500-today
If You Invested $100 In This Stock 5 Years...
04/10/2024 21:30:38

argus-research-maintains-buy-on-mckesson-raises-price-target-to-570
Argus Research Maintains Buy on McKesson, ...
04/10/2024 15:23:34

Argus Research analyst David Toung maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $510 to $570.

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-3200-today
If You Invested $1000 In This Stock 10 Yea...
04/03/2024 17:00:25

peering-into-mckessons-recent-short-interest
Peering Into McKesson's Recent Short Interest
03/28/2024 14:15:11

rite-aid-forges-path-to-financial-recovery-with-major-settlement-report
Rite Aid Forges Path To Financial Recovery...
03/27/2024 09:54:55

Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters repor...

mccormick-reaffirms-fy24-sales-growth-outlook-of-2---0-adj-eps-of-280---285-vs-283-est
McCormick Reaffirms FY24 Sales Growth Outl...
03/26/2024 10:35:20

100-invested-in-this-stock-5-years-ago-would-be-worth-400-today
$100 Invested In This Stock 5 Years Ago Wo...
03/18/2024 16:00:35

which-stocks-will-dominate-the-future-of-tech-ubs-shares-its-top-picks-in-ai-healthtech-greentech-and-fintech
Which Stocks Will Dominate The Future Of T...
03/18/2024 07:14:12

In a recent report, global wealth manager UBS has identified the sectors that are likely to drive the next wave of technologica...

ubs-maintains-buy-on-mckesson-raises-price-target-to-620
UBS Maintains Buy on McKesson, Raises Pric...
03/06/2024 17:43:50

UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $575 to $620.

how-is-the-market-feeling-about-mckesson
How Is The Market Feeling About McKesson?
02/27/2024 13:45:23

if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-13000-today
If You Invested $1000 In This Stock 15 Yea...
02/26/2024 17:30:19

leerink-partners-initiates-coverage-on-mckesson-with-outperform-rating-announces-price-target-of-600
Leerink Partners Initiates Coverage On McK...
02/26/2024 13:45:46

Leerink Partners analyst Michael Cherny initiates coverage on McKesson (NYSE:MCK) with a Outperform rating and announces Pri...

us-federal-trade-commission-investigates-drug-shortages-amid-allegations-of-market-manipulation
US Federal Trade Commission Investigates D...
02/14/2024 18:25:53

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scru...

mizuho-maintains-neutral-on-mckesson-raises-price-target-to-505-report-released-on-8th-february-2024
Mizuho Maintains Neutral on McKesson, Rais...
02/09/2024 15:51:40

Mizuho analyst Ann Hynes maintains McKesson (NYSE:MCK) with a Neutral and raises the price target from $450 to $505.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION